http://goldbamboo.com/ Cmv News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved http://goldbamboo.com/news-a221634.html AlphaVax Inc.'s novel alphavaccine technology has been shown to be effective in generating protection against congenital cytomegalovirus (CMV) disease in a preclinical study published in the March 15, 2007 issue of the Journal of Infectious Disease, the on-line version of which was distributed on February 14. [click link for full article] Tue, 20 Feb 2007 08:00 EST http://goldbamboo.com/news-a218055.html AlphaVax has been given approval by the Food and Drug Administration (FDA) to begin clinical trials evaluating vaccines for influenza and cytomegalovirus (CMV) developed with the company's alphavaccine technology. "These trials will expand on our previous clinical experience with an HIV vaccine to two additional indications, influenza and CMV," said Jeff Chulay, M.D. [click link for full article] Tue, 30 Jan 2007 08:00 EST http://goldbamboo.com/news-a222204.html U.S. researchers have developed an experimental vaccine that reduces stillbirths among rodents born to mothers infected with cytomegalovirus, or CMV. Thu, 22 Feb 2007 11:17 EST http://goldbamboo.com/news-a222604.html Researchers funded by the National Institutes of Health have developed an experimental vaccine that reduces stillbirths among rodents born to mothers infected with cytomegalovirus (CMV) - a common virus that can also cause mental retardation and hearing loss in newborn children who were infected in early fetal life.Estimates place the number of U.S. [click link for full article] Mon, 26 Feb 2007 06:00 EST http://goldbamboo.com/news-a222289.html Researchers funded by the National Institutes of Health have developed an experimental vaccine that reduces stillbirths among rodents born to mothers infected with cytomegalovirus (CMV) -- a common virus that can also cause mental retardation and hearing loss in newborn children who were infected in early fetal life. Thu, 22 Feb 2007 04:00 EST